Table 1. Demographic and clinical characteristics of the patient cohort.
| Characteristics | Eligible patients (n = 389) |
| Age (y) | |
| Mean±SD (range) | 44.62±10.27 (19–73) |
| Duration of symptoms (month) | |
| Mean±SD (range) | 11.0±3.3 (1–156) |
| CP/CPPS diagnosis, n (%) | |
| Inflammatory (Type IIIa) | 164 (42.2) |
| Noninflammatory (Type IIIb) | 225 (57.8) |
| NIH-CPSI scores, mean±sd (range) | |
| Total score | 24.51±7.02 (6–43) |
| Pain subscore | 10.68±3.17 (0–21) |
| Voiding subscore | 4.55±2.63 (0–10) |
| QoL subscore | 8.42±2.38 (2–12) |
| IPSS scores, mean±sd (range) | 11.26±7.50 (2–12) |
| Symptom severity, n (%) | |
| Mild | 92 (23.7) |
| Moderate | 209 (53.7) |
| Severe | 88 (22.6) |
| Median | |
| IIEF-5 scores, mean±sd (range) | 22.63±5.41 |
| ED severity, n (%) | |
| No ED | 268 (68.9) |
| Mild | 29 (7.5) |
| Mild to Moderate | 40 (10.3) |
| Moderate | 34 (8.7) |
| Severe | 18 (4.6) |
| Positive UPOINT domains, n (%) | |
| Urinary | 210 (54.0) |
| Psychosocial | 165 (42.4) |
| Organ specific | 163 (41.9) |
| Infection | 81 (20.8) |
| Neurological/systemic | 104 (26.7) |
| Skeletal muscle tenderness | 157 (40.4) |